What is the recommended dose of tetanus immunoglobulin (TIG) for post-exposure prophylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tetanus Immunoglobulin Dosing for Post-Exposure Prophylaxis

The recommended prophylactic dose of tetanus immunoglobulin (TIG) for post-exposure prophylaxis is 250 units administered intramuscularly (IM) for both adult and pediatric patients with tetanus-prone wounds. 1, 2

Indications for TIG Administration

TIG is indicated in the following situations:

  • Patients with tetanus-prone wounds who have:

    • Unknown vaccination history 1, 2
    • Incomplete primary tetanus vaccination series (<3 doses) 1, 2
    • Uncertain vaccination status 1
  • Tetanus-prone wounds include:

    • Contaminated wounds (dirt, feces, soil, saliva) 2
    • Puncture wounds 2
    • Avulsions 2
    • Wounds from missiles, crushing, burns, and frostbite 2

Administration Guidelines

  • TIG should be administered at the time of wound management 1

  • When tetanus toxoid (Td/Tdap) and TIG are administered concurrently:

    • Use separate syringes 1
    • Inject at separate anatomical sites 1, 2
    • The use of adsorbed toxoid is considered mandatory in this situation 1
  • In mass-casualty settings with limited TIG supply, priority should be given to:

    • Persons aged >60 years 1
    • Immigrants from regions other than North America or Europe 1, 2
    • These populations are less likely to have adequate antitetanus antibodies 1

Special Populations

  • Immunocompromised patients:

    • Persons with HIV infection or severe immunodeficiency should receive TIG regardless of their tetanus immunization history if they have contaminated wounds 2
  • Pregnant women:

    • Follow the same TIG guidelines as non-pregnant adults 2
    • Although no evidence suggests tetanus toxoids are teratogenic, waiting until the second trimester for Td administration is a reasonable precaution 1

Alternative Options

  • In circumstances where TIG is unavailable, intravenous immune globulin (IVIG) may be substituted 1
  • However, there are no data available about the efficacy of IVIG when used for tetanus prophylaxis 1

Important Considerations

  • Postexposure antimicrobial prophylaxis against tetanus is not recommended 1, 2
  • For clean, minor wounds, TIG is not needed regardless of vaccination history 2
  • Early administration of TIG is crucial as studies show no significant increase in tetanus antitoxin levels within the first 4 days following a tetanus toxoid booster 3
  • Intrathecal administration of TIG (250 IU) has shown benefit in treating early tetanus by reducing disease progression and mortality, but this is for treatment rather than prophylaxis 4, 5

Common Pitfalls to Avoid

  • Failing to administer TIG when indicated can lead to preventable tetanus cases 6
  • Relying solely on the time since last tetanus vaccination without determining the total number of previous doses received 1
  • Not using separate injection sites and syringes when administering TIG and tetanus toxoid concurrently 1
  • Administering TIG to patients with a history of severe Arthus-type hypersensitivity reactions to tetanus toxoid within the past 10 years 2

Remember that TIG provides immediate passive protection while tetanus toxoid vaccination stimulates active immunity that develops over time. Both are often needed for optimal protection in patients with tetanus-prone wounds and inadequate vaccination history.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tetanus Prevention and Treatment with Tetanus Immunoglobulin (TIG)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.